PURPOSE: The study was performed to assess the safety and efficacy of ultrasound (US)-guided percutaneous microwave (MW) ablation for @entity99 adjacent to the gallbladder. MATERIALS AND METHODS: From January 2011 to December 2013, 49 @entity1 with 51 @entity5 adjacent to the gallbladder who underwent US-guided percutaneous MW ablation were included in the study group. A total of 106 @entity1 with 117 @entity5 not adjacent to the gallbladder who underwent US-guided percutaneous MW ablation were included in the control group. In the study group the temperature of marginal ablation tissue proximal to the gallbladder was monitored and controlled at 45-54     C for 5-10   min during the ablation. @entity1068 (4.5-13   mL) was injected into the marginal tissue in 27 of 51 @entity5 of the study group. We compared the results of ablation between the two groups. RESULTS: All @entity1 were successfully treated. A total of 47 of 51 @entity5 in the study group (92.2%) and 110 of 117 @entity5 in the control group (94.0%) achieved complete ablation (p   =   0.93). Local @entity5 progression was found in nine (17.6%) @entity5 in the study group and 15 (12.8%) @entity5 in the control group during follow-up after MW ablation (p   =   0.41). No peri-procedural major complications occurred in either group. CONCLUSIONS: Under strict temperature monitoring, US-guided percutaneous MW ablation assisted with @entity1068 injection appears to be safe and can achieve a high rate of complete ablation for the treatment of @entity5 adjacent to the gallbladder.

Ultrasound-guided percutaneous microwave ablation for XXXX adjacent to the gallbladder.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatic malignancy'] @entity1068 :: ('MESH:D000431', 'Chemical') :: ['Ethanol', 'ethanol'] @entity5 :: ('MESH:D009369', 'Disease') :: ['hepatic malignant tumours', 'hepatic tumours', 'tumours', 'tumour']
@entity99 :: (MESH:D056486,Disease) :: ['hepatic malignancy']
